呼和浩特医院大便出血(呼市看肛裂呼市哪个医院好) (今日更新中)

Days after a dad was caught on camera being shot as he shielded his children from gunfire at Bronx car dealership, a family friend says he has lost his job.An innocent bystander, 39-year-old Anthony Jefferson was struck in the right thigh when the shooting erupted Monday, officials said.On a GoFundMe campaign page started Thursday by close friend Serena Wingate, she wrote that Jefferson had lost his job due to the injury and also has to have surgery to remove the bullet.Jefferson's wife, Danica Jefferson, told TMZ that the injury left him temporarily unable to walk. This has resulted in the heroic dad being fired from both of his two jobs as a construction worker and head painter at a maintenance company, TMZ reported.Wingate said she set up the GoFundMe to help the dad with medical bills and help his kids with therapy after the traumatic experience.According the family friend, the father and his three kids were at the dealership shopping for a new vehicle to surprise his wife for her birthday.That's when shots rang out inside the Boston Road business. Three men opened fire on another man, who fired several rounds back, police said.Surveillance video shows the dad diving and huddling over the kids on the floor behind a couch. Glass windows shattered as gunmen fired from between cars.None of the children were injured, police said.The NYPD is still trying to identify the men seen opening fire in the video.Submit tips to police by calling Crime Stoppers at 1-800-577-TIPS (8477), visiting www.nypdcrimestoppers.com, downloading the NYPD Crime Stoppers mobile app, or texting 274637 (CRIMES) then entering TIP577. Spanish-speaking callers are asked to dial 1-888-57-PISTA (74782). This article was written by Mark Sundstrom and Aliza Chasan for WPIX. 1793

INDIANAPOLIS — The U.S. Food and Drug Administration on Monday granted emergency use authorization to Eli Lilly and Company's experimental COVID-19 antibody treatment bamlanivimab.According to a statement from the company, the drug is authorized for the treatment of mild to moderate COVID-19 in adults and pediatric patients 12 years and older with a positive COVID-19 test who are at high risk for progressing to severe COVID-19 and/or hospitalization. Lilly said in a statement the drug should be administered as soon as possible after a positive COVID-19 test and within 10 days of symptom onset. The authorization allows for the distribution and emergency use of bamlanivimab, which is administered via a single intravenous infusion."This emergency authorization allows us to make bamlanivimab available as a COVID-19 treatment for recently diagnosed, high-risk patients — adding a valuable tool for doctors fighting the now-increasing burden of this global pandemic," David A. Ricks, Lilly's chairman and CEO, said. "The rapid development and availability of bamlanivimab could not have been achieved without the relentless work of our Lilly team, collaboration across the industry and the urgent work being done by the government to ensure appropriate allocation to patients who need it the most."The emergency use authorization is based on data from BLAZE-1, a randomized, double-blind, placebo-controlled Phase 2 study in patients with recently diagnosed mild to moderate COVID-19 in the outpatient setting. Patients treated with the drug showed reduced viral load and rates of symptoms and hospitalization, Lilly said in the statement. Infusion reactions and other allergic hypersensitivity events have been reported, Lilly said. The emergency use authorization includes a warning for hypersensitivity including anaphylaxis and infusion-related reactions.Lilly said the drug is not authorized for use in patients who are hospitalized due to COVID-19 or who require oxygen therapy due to COVID-19 or who require an increase in baseline oxygen flow rate due to COVID-19 in those on chronic oxygen therapy due to underlying non-COVID-19 related comorbidity."The BLAZE-1 data show bamlanivimab, when given early in the disease course, may help patients clear the virus and reduce COVID-related hospitalizations, supporting our belief that neutralizing antibodies can be an important therapeutic option for patients fighting this virus," Daniel Skovronsky, M.D., Ph.D., Lilly's chief scientific officer and president of Lilly Research Laboratories, said. "We're proud of the speed with which we have been able to bring patients this therapy specifically designed to treat COVID-19. We thank those who have contributed to this medical advancement, particularly the clinical trial investigators and participants around the country." This article was written by Bob Blake for WRTV. 2906

www.apple.com/privacy/?afid=p238%7CsaVvcGIwI-dc_mtid_20925d2q39172_pcrid_339397270208&cid=wwa-us-kwgo-iphone-slid---+apple++data-b 146

New transportation options are showing up in cities across the country, including shareable bikes, electric scooters, and now mopeds are even starting to compete for street space.However, with all these new electronic transportation options there are safety concerns. Starting this weekend, 400 electric mopeds will be hitting the streets of Washington, D.C. One thousand of the mopeds are already available for rent in New York City. The company behind these electric mopeds, Revel, plans to expand to other cities. “The benefit is really simple. The way you have to think about it: this is almost always at least half the cost of Uber and Lyft and twice as much fun,” says Paul Suhey with Revel. They're part of a growing number of transportation options people can rent by using their cell phone app. Most major cities already have electric scooters and bicycles. Last year in the U.S., people took 84 million trips on bikes and scooters, according to National Association of City Transportation officials. However, the influx of rides is causing safety concerns, with some concerned the vehicles will add to the congestion on the road. “If you're having to be aware of either a cyclist, a scooter rider, now a moped rider, who may go in between cars, you have to be careful and watch out for each other as you're using these different modes of operations,” says Jeanette Tejeda de Gomez with AAA. She says research shows moped riders are more likely to be injured or die than those walking, biking or driving a car. However, Revel says helmets are included with each rental, riders have to be at least 21, have a driver's license and they screen the rider's driving record. “From our first couple months operating in New York, in over 300,000 rides, 99.99 percent have happened without incident, and we understand that safety record doesn't happen by accident,” Suhey says. Whether or not you’re ready to see these mopeds in your city, there’s no doubt on-demand transportation is now a driving force for new ways to get around. 2047

who walked into the media spotlight with her newborns in her arms, hours after giving birth at a hospital in central London 139

来源：资阳报